Trabectedin led to the recruitment of CD8+ and CD4+ T cells to tumours in the more aggressive mouse model mOS69, which does not normally exhibit vast T cell infiltration, and increased expression of checkpoint inhibitor PD-1 on CD8+ cells, indicating T cell exhaustion. The gene discussed is CD8A; the disease is neoplasm.